Group III/IV muscle afferents transduce nociceptive signals and modulate exercise pressor reflexes (EPR).
Introduction
Group III and IV primary muscle afferents are subpopulations of thinly myelinated (III) and unmyelinated (IV) fibers with a variety of sensory capabilities that include mechanical-, thermal-, chemo-sensation (1) (2) (3) . Group III/IV muscle afferents have two distinct functions. First, these neurons can serve as sensory transducers of noxious and non-noxious peripheral stimuli from the muscles (2, 4) . Second, they also function as the sensory arm for the exercise pressor reflex (EPR), the cardiovascular response to muscle contraction that includes increased blood pressure and heart rate (5) (6) (7) (8) . Each of these biological processes are influenced by the different sensory modalities of group III/IV afferents (9) (10) (11) (12) (13) (14) (15) .
A common method to study the involvement of peripheral sensory neurons in both nociception and sympathetic reflexes is to use a skeletal muscle ischemic injury model (21, (27) (28) (29) (30) (31) . After ischemic injuries, group III and IV muscle afferents display peripheral sensitization, including increased responsiveness to mechanical and chemical stimuli. Ischemia also increases the response to muscle contractions of ~50% of group IV and ~12% of group III muscle afferents (28). This correlates with observed changes in nociceptive behaviors, EPRs, and gene expression in the affected muscles and dorsal root ganglia (DRGs) (9, 21, 27, 30, 32) .
Chemo-reception and mechanical responsiveness of primary muscle afferents have been attributed to expression of a combination of both acid sensing ion channels (ASICs) and purinergic, P2X receptors (9, (16) (17) (18) (19) (20) . Each of these ion channels have also been associated with altered nociception and EPR modulation after ischemic injury (10, (21) (22) (23) . P2X and ASIC channel activity has been linked to sensing of fatigue and ischemic pain (9, 16) by disrupting the metabolite responses of DRG neurons (9, 11, 16) . P2X5 has also been shown to modulate the pH sensitivity of ASIC3 (16) , which may further shape afferent and behavioral responsiveness. The role of these channels in the normal mechanical responses of nociceptors is not as clear, but both ASIC3 and P2X receptors have been linked to mechanical hypersensitivity in different injury models (9, 17, 20, 21, 25, 26) .
Results

I/R upregulates GDNF in the affected muscle and various gene expression changes in the DRGs that correlate with behavioral hypersensitivity.
In our previous reports, we did not observe a significant increase in the expression of many growth factors in the I/R affected muscle tissue such as NGF, BDNF and Artemin. However, GDNF was significantly upregulated (30) . To therefore characterize the role of GDNF signaling after I/R, we first quantified the amount of GDNF protein in muscle tissue by Western Blot. This analysis revealed an increased amount of GDNF in the I/R injured muscles compared to naïve mice 24h after injury (Fig. 1A) . Immunohistochemical labeling experiments revealed expression of GDNF around and within myofibers ( Fig 1B) .
While GDNF showed increased expression in the I/R-injured muscle, its receptor, GFRα1, was upregulated in the I/R-affected DRGs (Fig 1C) . In order to test the specific effects of GFRα1 upregulation in DRG neurons, we used our previously described nerve-specific siRNA-mediated knockdown strategy to block dynamic injuryrelated gene expression (21, 27, 51, 53, 54) . We verified the effectiveness of the siRNA knockdown strategy via realtime PCR and Western Blot. To control for the nerve injection, a separate group of I/R-injured mice was injected with non-targeting siRNAs (PenCON+I/R). The PenCON+I/R mice showed the same increased mRNA expression of GFRα1 (438%±32%; p<0.05 vs. naive) as the I/R mice without siRNA injections (236%±17%; p<0.05 vs naive), while the Penα1+I/R mice (0%±19%; p>0.05 vs naïve; 1-way ANOVA with HSD post hoc) showed expression levels similar to the naïve animals. Comparable results were also obtained at the protein level (Fig 1C) .
We then performed a variety of behavioral tests in I/R injured animals with nerve-targeted GFRα1 knockdown.
In these experiments, sham surgery control was used for comparisons. I/R-injured and PenCON injected animals with I/R showed increased paw guarding scores compared to sham injured animals at 1d. I/R-injured mice with GFR1 knockdown (Penα1+I/R) however show significantly reduced paw guarding (Fig 1D) .
Withdrawal thresholds to von Frey filament stimulation of the plantar surface of the fore paw were also significantly decreased in the I/R and PenCON+I/R groups compared to sham injured animals. This mechanical hypersensitivity was completely prevented by the Penα1 injection (Fig 1E) . Similar results regarding mechanical hypersensitivity were also obtained in groups that underwent hind paw muscle squeezing (Fig 1F) .
Grip strength was decreased after I/R alone and in the PenCON+I/R group. This decrease in grip strength was partially prevented by GFRα1 targeting siRNAs (Fig 1G) . Finally, we tested the cardiovascular response to exercise before and following injury to measure blood pressure and heart rate after a low intensity exercise.
This running protocol has been previously determined to be sufficient to induce an EPR response but not strong enough that it can induce pain-related hypersensitivity (5) . I/R-injured and PenCON+I/R mice showed a significant increase in the mean arterial pressure (MAP) one day after injury when compared with their preexercise baseline. This significant increase in MAP was completely absent in sham injured or Penα1+I/R mice ( Fig 1H) . We did not detect any change in the heart rate after exercise either before or 1 day after I/R injury (not shown). Results collectively indicate that afferent GFR1 upregulation in the DRG is important in dually modulating nociception and EPRs after I/R.
GFRα1 upregulation modulates primary afferent sensitization after I/R.
To test the hypothesis that GFRα1 upregulation played a role in afferent sensitization after I/R, we performed electrophysiological recordings in an ex-vivo muscle, nerve, DRG, spinal cord preparation. As previously reported (21, 30), we found that primary group III and IV muscle afferents from I/R and PenCON+I/R mice have decreased mechanical thresholds compared to naïve animals. GFRα1 knockdown prevented observed mechanical sensitization in sensory neurons (Fig 2A, 2B) . As shown in our previous work (21, 30) , naïve afferents in the current report were found to respond almost exclusively to either 15 mM lactate, 1 µM ATP, pH 7.0 ("low" metabolites) or 50 mM lactate, 5 µM ATP, pH 6.6 ("high" metabolites), but not both (Fig 2C) . I/R and PenCON+I/R groups showed an increase in the total number of afferents that responded to stimulation of the muscles with both "low" and "high" metabolite mixtures. This phenotypic change was prevented by selective GFRα1 knockdown. Penα1+I/R mice not only showed responses exclusively to one or the other concentration of metabolites, but surprisingly the percentage of afferents recorded showing any response to metabolites was lower than that observed in naïve animals ( Fig 2C) . This suggests that GFRα1 upregulation not only plays a role in afferent mechano-sensation after I/R, but is also important for chemo-sensory functions of group III/IV afferents.
GFRα1 regulates select changes in DRG gene expression after I/R
The increased expression of GFRα1 in the affected DRG was accompanied by a significant upregulation of various genes encoding receptors involved in sensory transduction. Similar to previous reports (9, 10), we found that the acid sensing ion channels 1 (ASIC1) and ASIC3, and purinergic receptors P2X3, P2X4 and P2X5 were significantly upregulated 1d after I/R. Other receptors from the GFR family, including GFRα2 and GFRα3 were not upregulated after I/R. The tyrosine receptor kinase (trk) family of receptors trkA, trkB and trkC were also not upregulated in the DRGs after I/R (Table 1) .
We therefore assessed the effects of GFR1 knockdown on upregulated receptor expression in the DRGs after I/R. We did not find any significant difference in the expression levels of ASIC1, ASIC3, P2X3, P2X4, P2X5 or GFRα1 between I/R and PenCON+I/R mice (not shown) and thus grouped the data for simplicity of presentation (I/R Control). As shown in Table 2 , Penα1+I/R animals showed a significant decrease in the expression level of ASIC3, but not ASIC1 compared to I/R injured animals. However, knockdown did not completely revert levels of ASIC3 to that observed in uninjured mice. Interestingly, the only purinergic channel whose increased expression was significantly blocked by selective GFRα1 knockdown after I/R was P2X5. No I/R induced changes in P2X3 or P2X4 were observed in mice with Pen1 injection plus I/R. These latter results were then corroborated by total cell counts in the DRGs where I/R and PenCON+I/R animals showed a significant increase in the total number of individual cells positive for either GFRα1 or P2X5, and the total number of neurons co-expressing GFRα1 and P2X5 (Fig. 3) . Both of these increases in total number of immunopositive cells were prevented by selective knockdown of GFRα1, suggesting a direct relationship between GFRα1 and P2X5 expression after injury.
To gain better insight on whether the phenotypic alterations in chemosensitive muscle afferents induced by I/R corresponded with the expression of GFR1 and P2X5, after electrophysiological characterization of identified muscle afferents, we filled chemosensitive neurons with neurobiotin and performed immunohistochemistry on the DRG containing the labeled neuron. As shown in Figure 3E and Table 3 , after I/R, ~90% (9/10 GFRα1+, 9/10 P2X5+) the neurons that became responsive to both metabolite mixtures expressed either P2X5 or GFRα1 and 80% of these expressed both receptors (8/10 GFRα1+/P2X5+). In the "low" responder subpopulation, only 25-30% of cells were positive for both receptors (1/4 in Naïve, 1/3 in I/R Control and 0/1 in Penα1+ I/R, Table   3 ). This suggests that while the co-expression of GFRα1 and P2X5 is not a requirement for the normal chemosensitive function of metaboreceptors, there may be a strong link between the co-expression of both GFRα1 and P2X5, and the phenotypic switch observed in chemosensitive primary muscle afferents after I/R.
P2X5 plays an important role in the development of pain related behaviors and increased EPRs after I/R.
qPCR results suggested that GFRα1 regulated the development of muscle pain-related behaviors and exacerbated EPRs after I/R through modulation of the expression of ASIC3 and/or P2X5. Since we previously have shown that ASIC3 is crucial for I/R-related peripheral sensitization (21), here we assessed the role of P2X5 on these phenomena. Using similar strategies to that described for GFR1 knockdown, we confirmed that injection of Penetratin-linked P2X5 targeting siRNAs into the median and ulnar nerves of mice with I/R was able to completely block the I/R induced upregulation of this channel at the mRNA (I/R: 70%±10%; p<0.01 vs naïve; PenCON+I/R: 70%±20%; p<0.01 vs naïve; PenX5: -65%±36%;p>0.001 vs naïve; 1-way ANOVA with HSD post hoc) and protein levels (Fig 4A) . Behavioral testing revealed that animals injected with P2X5-targeting siRNAs (PenX5+I/R) had lower guarding scores than both I/R and PenCON+I/R treated animals, although this did not reach sham levels (Fig. 4B) . Reduced mechanical withdrawal thresholds to von Frey filament stimulation (Fig. 4C) were partially reversed by P2X5 knockdown after I/R. However, the reduction in muscle withdrawal thresholds to forepaw muscle squeezing ( Fig 4D) were not significantly inhibited in the PenX5+I/R group. Grip strength deficits were partially rescued from the effect of I/R by PenX5 injection (Fig. 4E) . Interestingly, PenX5 injection completely prevented the exacerbation of the EPR after I/R, similar to that observed with Penα1 injection. Results suggest that P2X5 (in possible conjunction with other receptors like ASIC3 (21)), plays an important role in the development of pain related behaviors and enhanced EPRs after I/R.
CREB binding protein (CBP) inhibition prevents I/R induced overexpression of P2X5 and the development of ischemic-myalgia-like behaviors.
Results suggested that enhanced GDNF/GFR1 signaling increased P2X5 (and ASIC3) expression in muscle afferents to dually modulate nociception and EPRs after I/R. However, we did not know how GDNF signaling influenced transcription. We therefore performed RT array analysis of DRGs from mice with I/R to perform an unbiased screen of several transcription factors simultaneously. Surprisingly, no transcription factors were upregulated at the mRNA level in the DRGs 1d after I/R using this approach (Supplementary Table 1 ). We therefore retrogradely labeled afferents from the forepaw muscles using fluorogold, dissociated the DRGs in vitro and treated them with GDNF. Unlike our previous reports analyzing IL1 treated muscle afferents (21), GDNF was not found to alter the numbers cells containing activated c-Jun-N-terminal kinase (p-JNK). GDNF also did not increase the numbers of cells with phosphorylated mitogen activated protein kinase (MAPK) p38
( Supplementary Fig 1) .
Since our previous reports suggested that MAPKs such as extracellular signal related protein kinases 1/2 (ERK1/2) were not upregulated or activated by I/R in the DRGs (21), we performed additional WB analysis from I/R injured animals to assess other putative transcription factors that may be activated (phosphorylated) at the protein level by increased GDNF/GFR1 signaling. Although no changes in pERK5 were detected (not shown), we found that cAMP response element binding (CREB) protein was phosphorylated after I/R in the DRGs. However, Pen1 injection did not fully prevent I/R-induced CREB phosphorylation (Fig. 5A ). Since CREB has been linked to receptor tyrosine kinase signaling (55, 56) , and these molecules execute their functions through transcription factor complexes (57-60), we decided to assess the CREB binding protein (CBP) in mice with I/R. Not only did I/R upregulate CBP along with activation of CREB, but knockdown of GFR1 in the DRGs after I/R prevented CBP upregulation (Fig. 5A ).
We therefore used a pharmacological approach to assess whether disruption of the CBP/CREB transcription factor complex could blunt I/R-related hypersensitivity and altered EPRs. Treatment of mice with the CBP antagonist, xx-650-23 not only inhibited the ischemic-myalgia-like behaviors after I/R ( Fig. 5B-F ), but it also reduced the levels of P2X5 in the DRGs (Fig. 5G) . Results indicated that I/R related-behaviors modulated by increases in GDNF/GFR1 signaling, regulates P2X5 induction at least in part through modulation of CREB/CBP-mediated transcription.
Targeting GDNF directly in the injured muscles effectively prevents the development of pain-related behaviors and exacerbated EPRs after I/R.
To test whether targeting increased levels of muscle GDNF directly could prevent ischemic myalgia-like behaviors, we then injected either anti-GDNF antibodies, vehicle or IgG into the affected forepaw immediately after sham or I/R and assessed pain-related behaviors and EPRs one day after injury. Mice injected with vehicle or IgG were not found to be different from each other (not shown). However, as indicated for GFR1, P2X5
and CBP inhibition, GDNF antibody injection into the muscles significantly inhibited I/R-induced paw guarding, mechanical hypersensitivity, grip strength and altered EPRs compared to control antibody injected mice with I/R (Fig. 6 ).
Discussion
In this report, we describe a novel mechanism of muscle afferent sensitization after ischemia with reperfusion injuries that regulate the development of pain-related behaviors and exacerbated cardiovascular responses to exercise. Peripheral sensitization after I/R was modulated by increased GDNF from injured muscles acting upon upregulated GFRα1 in DRG neurons which (among other possible players) modulated CREB/CBP dependent transcription of P2X5 (Fig. 7) .
Multiple models of musculoskeletal pain have suggested a prominent role for GDNF signaling (44) (45) (46) . Various studies have shown that chemosensitive group III and IV muscle afferents are the sensory arm of the exercise pressor reflex and that ischemic injuries are capable of increasing their response to metabolite stimulation and muscle contraction (5, 10, 28, 61) . In addition, group III and IV primary muscle afferents also function as nociceptors and can be sensitized by ischemic injury. GDNF/GFR1 signaling is likely to be a major aspect of I/R-related hypersensitivity. Of all combinations of growth factors and their receptors upregulated in the muscles and DRGs, only GDNF and GFR1 were collectively induced after I/R (30) ( Table 1) . Selective knockdown of GFRα1 in muscle afferents partially prevented injury-related paw guarding and completely blocked the I/R-induced decrease in mechanical withdrawal thresholds to VFH stimulation and to muscle squeezing ( Fig. 1) .
Interestingly, GFRα1 knockdown was only partially effective in preventing the decreased grip strength observed after injury suggesting that there are other mechanisms involved in altering specific muscle-related tasks after I/R such as cytokine-mediated regulation of ASICs (21) . Previous work from our lab showed that preventing the I/R-induced upregulation of IL1r1 in DRGs completely prevented ASIC3 induction and in turn fully prevented the development of all pain-related behaviors after injury (21, 31) . Studies using ASIC3 knockout mice report a lack of mechanical hyperalgesia after muscle inflammation that can be restored by expressing ASIC3 in the neurons innervating the affected tissue (18, 19) . However, in this report, selective knockdown of GFRα1 fully blocked the I/R induced upregulation of the purinergic receptor P2X5, but only partially that of ASIC3. Together this provides a plausible explanation as to why Penα1 injection only partially blunted I/R-induced paw guarding and injury-reduced grip strength. Thus, pain-related behaviors and altered EPRs from I/R are due to activation of several signaling pathways that likely includes both cytokine and growth factor signaling mechanisms.
At the sensory neuron level, GFRα1signaling appeared to play a role in the development of primary afferent mechanical hypersensitivity after I/R, as GFR1 knockdown blocked I/R induced reductions in group III/IV muscle afferent thresholds (Fig. 2) . In addition, we observed a phenotypic switch from observing mostly two mutually exclusive sub-populations of chemosensitive fibers, metaboreceptors (low metabolite responders) or metabo-nociceptors (high metabolite responders), to a subpopulation that became responsive to both "low" and "high" metabolite concentrations. This finding, confirms our previous reports of a phenotypic switch after I/R (21, 30) , but in contrast with this earlier study, selective knockdown of GFRα1 after I/R did not revert the phenotypic switch. Instead, it vastly decreased the numbers of detectable chemosensitive neurons, suggesting that GFRα1 signaling, especially after I/R, plays an important role in the maintenance of peripheral chemosensitivity.
This result could be explained by the downstream effects on P2X5 (Figs. 3-5 ), a key player in the chemosensitive function of muscle afferents (9, 16) . P2X5 has been shown to modulate the pH sensitivity of ASIC3 in vitro (16) . Previous work showed exposure to a combination of metabolite stimuli is necessary to effectively activate chemosensitive afferents (1, 9) . Thus, it is reasonable to suggest that disrupting one of the components of the chemosensitive apparatus could render the primary neurons incapable of responding to a chemical stimulus (depending on the concentrations or combinations of metabolites present) (9) . This could also explain why Penα1+I/R mice and PenX5+I/R mice do not exhibit an increased EPR after injury as chemosensitivity of group III/IV muscle afferents is a key component of EPR function (6, 10, 13, 22, 62, 63) .
Nevertheless, regulation of P2X5 expression via CREB/CBP dependent transcription (Fig. 6 ) may be a key means through which GFRα1 modulated muscle afferent sensitization after I/R. An important consideration is that not all chemosensitive neurons are the same regarding GFR1 or P2X5. Our neurochemical analysis of functionally identified chemosensitive neurons shows that metaboreceptors ("low" metabolite responders) may only partially rely on GFRα1 or P2X5 as only ~33-25% (Table 2 ) of these cells coexpressed both receptors. In contrast, metabo-nociceptors (high metabolite responders), often express both GFRα1 and P2X5 (Fig. 4) . After I/R, the new subpopulation of afferents that responds to both metabolite concentrations almost always co-expresses GFRα1 and P2X5, reinforcing the idea that enhanced co-expression of both receptors is important in the observed phenotypic switch in chemosensitive neurons after I/R.
The behavioral experiments on P2X5 targeted knockdowns somewhat support this notion, as the guarding scores on PenX5+I/R mice almost perfectly mimic those observed in the Penα1+I/R group. Yet, both mechanical hypersensitivity and muscle function were not rescued by PenX5 injection, suggesting that this aspect of afferent sensitization may be explained by concurrent cytokine/ ASIC signaling (21) . Nevertheless, P2X5 knockdown in I/R affected afferents was quite effective in preventing exacerbated EPRs one day after injury, highlighting the importance P2X5 in modulating the chemosensitive function of muscle afferents. This complements previous in vitro reports that showed P2X5 can modulate ASIC3 pH sensitivity and could explain the increased behavioral and cardiovascular responses observed after injury here (16) . Future studies are thus needed to assess afferent sensitization in mice with I/R and P2X5 knockdown.
Despite these novel findings, the origin of the observed increase in muscle GDNF levels after I/R is still up for debate. Our results suggested that GDNF could come directly from the I/R-affected myofibers (Fig. 1) .
Previous studies support this notion in that skeletal myofibers themselves are capable of releasing GDNF (64, 65) . The immunohistochemistry performed in injured muscles also shows a distinct "halo-like" pattern around the injured muscle cells that highly resembles previous reports hinting that GDNF could originate in myocytes (65) . While the effect of GFRα1 upregulation in the DRG after I/R appears to be an important player in injuryrelated hypersensitivity, the cause of increased receptor expression was not elucidated. Additional studies are also needed to determine how GFRα1 is initially upregulated after injury.
The observed increase in MAP after I/R resembles previous reports in other models of ischemic insult (27, 28, 63, 66, 67) . However, this is the first report where unilaterally targeting a neurotrophic factor or its receptor, prevented the development of exacerbated EPRs post injury. While we were able to detect an exacerbated MAP after I/R, we did not observe significant changes in heart rate (HR) after exercise before or after injury. This could be due to a fast recuperation of HR after exercise compared to the observed MAP changes. Nonetheless, the fact that our strategies targeting GDNF/GFRα1 were effective at preventing the exacerbated EPR after I/R reveal how important this signaling pathway may be for the sensitization of muscle afferents and subsequent effects on cardiovascular reflexes or nociceptive-like responses.
Clinical Significance
Patients that experience pathologies characterized by musculoskeletal ischemic injury, such as sickle cell disease, PVD, or complex regional pain syndrome (CRPS) often present both pain and altered autonomic vasomotor responses to tissue ischemia (48, (68) (69) (70) (71) . Our data suggests that muscle GDNF, combined with GFRα1 upregulation can sensitize muscle primary afferents after I/R. To determine whether targeting this pathway was a potential therapeutic for I/R-related hypersensitivity, we targeted GDNF at the source by injecting antibodies into the I/R injured muscles similar to strategies used in other disease models (72) (73) (74) (75) . Our results highlight the potential therapeutic value of blocking this pathway at the source in ischemic injuries as our mice displayed reduced pain-related behaviors and EPRs after I/R upon intramuscular injection of GDNF targeting antibodies (Fig. 7) . Results thus suggest that reducing GDNF signaling may be an option to treat patients that suffer musculoskeletal ischemic injuries and that this strategy may not only alleviate their pain, but also prevent cardiovascular complications associated with this injury. 
Methods
Animals
Induction of ischemia with reperfusion injury
Ischemia with reperfusion injury (I/R) was induced as previously described (30) . Briefly, mice were anesthetized with 3% isoflurane, and then under a dissection microscope, a small incision was made on the right forelimb above the elbow. The right brachial artery was exposed proximal to the ulnar artery/radial artery split.
The vessels were gently loosened from adjacent connective tissue and then the brachial artery was tied using a 7-0 silk suture using a loop knot. Incisions were closed with 6-0 silk sutures, and six hours after performing the occlusion surgery, a second surgery was performed to remove the suture around the artery. Except for the baseline behavioral time points, all assessments were performed 18 hours after the suture removal (reperfusion).
For comparisons, some mice received a sham I/R surgery in which a suture was placed under the artery as described above, but it was not tied.
Nerve-targeted siRNA injections
Specific targeting siRNAs were used to selectively knockdown the expression of either the GDNF receptor, GFRα1, or the ATP receptor, P2X5 (Thermo). siRNAs were conjugated to Penetratin-1 (MP Biomedicals) as previously described (27, 53, 54, 76). The duplex used for each target in these experiments was determined to have the highest targeting efficiency based on the knockdown efficacy of four different targeting siRNAs tested in Neuro2A cells in vitro (not shown). The duplex used in the current study that was found to most efficiently target GFRα1 was as follows: sense: 5'-S-S-CGACAAAGUUCCAGCCAAGUU; anti-sense: 5'-P-CUUGGCUGGAACUUUGUCGUU. The duplex used to target P2X5 was: sense: 5'-S-S-CAACAUUGGUUCCGGGCUGUU; anti-sense: 5'-P-CAGCCCGGAACCAAUGUUGUU. The non-targeting control siRNA used this study is the same as in previous work from our lab (21, 27, 54) , and has been determined to not target any gene in the mouse genome (Thermo; Cat#: D-001206-14-05).
Two days before I/R, mice were anesthetized as described. A small incision was made in the inner midforelimb region, proximal to the elbow and exposed the ulnar and median nerves to be injected. siRNAs were heated to 65°C for 5 min prior to injection. 0.1-0.2 μL of 90 μM penetratin-1 linked non-targeting, control (PenCON), GFRα1-targeting (Penα1), or P2X5-targeting siRNAs (PenX5) were pressure injected directly into the median and ulnar nerves using a quartz microelectrode connected to a picospritzer. This procedure does not cause significant injury to the sensory neurons being studied and does not it induce antiviral related responses (21, 51, 53, 54) .
Antibody injections:
Immediately after the occlusion surgery and while still under isoflurane anesthesia, cohorts of mice were slowly injected with 10µg of either anti-GDNF, antibody (ANT-014, Alomone labs, Jerusalem, Israel), IgG (AB-105-C, R&D Systems, Minneapolis, MN, USA) or vehicle (sterile water) in a volume of 5µL into the right forepaw muscles using a 30 gauge needle. Antibody dose was determined from Murase et al (45) . Reperfusion surgery in these mice was performed 6h later as described above.
CREB binding protein (CBP) antagonist injections:
The compound xx-650-23 was used to block the interaction between the cAMP response element-binding to determine the dose used in these experiments (20mg/kg). Mice were allowed to recuperate after the injection and reperfusion followed 6h later.
Measurement of pain-related behaviors and exercise pressor reflexes (EPRs)
Separate groups of sham, I/R, siRNA+I/R (PenCON+I/R, Penα1+I/R or PenX5+I/R), local antibody injection+I/R (anti-GDNF+I/R, IgG+I/R or vehicle+I/R), or antagonist+I/R (xx-650-23+I/R or 0.1% DMSO+I/R) were used for behavioral analysis (n = 10 per group). Testing of pain-related behaviors was performed as previously described by Ross et al., 2014 . Briefly, mice were first tested at baseline, one day prior to injury (I/R), and then again one day post injury. All behavioral testing was performed in the morning. The experimenter was blinded to both treatment and injury condition of the animal.
Nociceptive testing included 4 behavioral assessments: forepaw guarding, von Frey filament stimulation of the plantar surface of the forepaws, and forelimb grip strength, in this order. Fore paw muscle squeezing was performed in independent cohorts (below). Mice were placed in a raised acrylic glass chamber with a steel mesh bottom and allowed to habituate for at least 30 minutes. To evaluate guarding behavior, mice were assigned a score of 0 to 2 (0 = mouse places foot firmly on mesh, 1 = mouse does not bear full weight on foot, 2 = mouse holds foot completely above mesh) every 5 minutes for 12 total observations. The average score for the 12 trials was determined for each mouse per behavioral day. Mechanical withdrawal thresholds on the forepaws were then determined by stimulating the plantar surface with an increasing series of von Frey filaments (0.07 g to 4 g). Threshold to withdrawal was recorded for at least 3 trials with 5-minute intervals between stimulations, and the average of the 3 trials was used for analysis. Mice were then assayed for forepaw muscle strength using a grip strength meter (BioSeb, Vitrolles, France). Animals were held by the tail over a metal grid until they firmly held it with both fore paws but were not allowed to grip the grid with their hind paws. Then they were quickly pulled back horizontally (along the axis of the force sensor) until they could not retain their grip. Grip strength was measured (in g) in 3 rounds of 3 trials each, with 5 minutes between each round. The average of the nine trials was used for analysis. Finally, cohorts of mice were tested using a digital Randall-Sellito device (IITC Life Science Inc. Woodland Hills, CA, USA) to assess withdrawal thresholds to muscle squeezing. In order to diminish the stimulus applied to the skin and maximize the stimulus to the muscle we used a blunt, rounded probe ~1.5mm wide, similar to approaches previously described (77, 78) . To prevent injury due to excessive pressure, a cutoff pressure was set to 400g. Animals were subjected to 3 trials with an interval of 5 minutes between each test. Average of the three trials was used for analysis.
After all pain-related behavioral assessments, the exercise pressor reflex (EPR) was then determined by using a low intensity, forced run protocol based on previous work by our lab and others (27, 79, 80) . Before and immediately after the exercise session, each mouse was placed in a small acrylic restrainer adequate for its size and weight, allowed a short period of acclimation (approximately 5 minutes) and had its blood pressure and heart rate measured 45 times (maximum number obtained per mouse) with a tail cuff BP system (Kent Scientific, Torrington, Connecticut, USA). Data was collected using CODA software (Kent Scientific) and analyzed offline. The first 5 measurements were used to acclimate the mice to tail cuff inflation and were not used for analysis. Unreliable measurements were automatically discarded by the software and manually when the animal showed excessive movement that generated signal artifacts.
For the exercise protocol, the mice were run on a modular treadmill (Columbus Instruments, Columbus Ohio) at 0° of inclination with an increasing ramp speed going from 9 m/min up to a maximal speed of 13 m/min for a total distance of 500m. Speed was increased 1 m/min per minute, thus the entire running protocol lasted approximately 40 minutes. This speed is around 75% the mean critical speed for mice and is well below the speed and distance previously reported to induce anaerobic metabolism in the muscle or tissue damage in mice (27, 81, 82) . This exercise protocol has also not been shown to induce pain-related hypersensitivity due to ischemic injury (27).
Ex vivo recording preparation
Ex vivo recording was performed as previously described by Jankowski et al (2013) SC was hemisected and the median and ulnar nerves along with the forelimb muscles they innervate (with bone left intact) were dissected in continuity with their respective DRGs (C7, C8, and T1). After dissection, the preparation was transferred to a separate recording chamber containing cold, oxygenated aCSF. The forepaw was pinned on an elevated platform, keeping the entire paw perfused in a chamber isolated from the DRGs and the SC. Finally, the bath was slowly warmed to 32°C before recording from the DRGs.
All single unit recordings were made from the C7, C8, and T1 DRGs as these are the primary source of muscle afferent fibers in the median and ulnar nerves. Sensory neuron somata were impaled with quartz microelectrodes (impedance>150MΩ) containing 5% Neurobiotin (Vector Laboratories, Burlingame, CA) in 1M potassium acetate. Electrical search stimuli were delivered through a suction electrode on the nerve to locate sensory neuron somata with axons in the median and ulnar nerves. The latency from the onset of this stimulus and the conduction distance between the DRG and the stimulation site (measured directly along the nerve), were used to calculate the conduction velocity (CV) of the fibers. Group IV afferents were classified as those with a CV≤1.2 m/s, and group III afferents were those with CVs between 1.2 and 14 m/s (1, 27).
Peripheral receptive fields (RFs) in the muscles were localized by electrically stimulating the muscles with a 
Immunohistochemistry
Once a sensory neuron was characterized and intracellularly filled with Neurobiotin, the DRG containing the injected cell was removed and immersion fixed with 3% paraformaldehyde in 0.1 M phosphate buffer (PB).
DRGs were fixed for 30 min at room temperature (RT) and then changed to PB for storage before embedding in OCT embedding medium. Embedded DRGs were stored at -80°C, sections (15 µm) were cut on a cryostat and mounted on slides and processed for GDNF receptor GFRα1 (goat anti-GFRα1, 1:100; cat no. AF-560, R&D 
Quantification of DRG neurons
Total cells containing GFRα1 and P2X5 were quantified in DRGs (C7 or C8) from naïve mice, or mice that underwent I/R alone, PenCON+I/R, Penα1+I/R or PenX5+I/R (n=3 per condition). The DRGs were taken after electrophysiological experiments and were processed for immunohistochemical analysis as described above.
The numbers of positive cells were determined using a slightly modified methodology as previously reported by Christianson et al (2006) and Jankowski et al (2009) to account for the thinner (15m) sections obtained for immunocytochemical processing here. In brief, three non-consecutive groups containing three sections in series (45m total) were randomly chosen and Z-stacks were generated at 3µm intervals to create 15µm thick optical sections using a Nikon confocal microscope with sequential scanning. The number of GFRα1-positive and P2X5-positive cells in each group were counted using Neurolucida software ensuring that the same cell was not counted twice including those in serial sections, averaged and reported as mean ± SEM.
Western Blotting
C7-T1 DRGs were collected from the right side of sham injured, I/R, PenCON+I/R, Penα1+I/R, PenX5+I/R, xx-650-23+I/R or 0.1% DMSO+I/R mice (n=3 per condition). DRG tissue was pooled (2 mice of the same condition per sample). Forepaw muscle tissue was also collected from sham injured and I/R treated mice. All samples were collected one day after I/R in all groups. Tissue was homogenized in lysis buffer containing 1% sodium dodecyl sulfate (SDS), 10 mM Tris-HCl (pH 7.4), and protease inhibitors (1 µg/mL pepstatin, 1 µg/mL leupeptin, 1 µg/mL aprotinin, 1 mM sodium orthovanadate, and 100 µg /mL phenylmethylsulfonyl fluoride RNA isolation and reverse transcription, realtime PCR and transcription factor PCR arrays DRG (C7-T1, right side) tissue was collected from cohorts of naïve, I/R, PenCON+I/R and Penα1+I/R mice.
Separate cohorts of the same conditions were collected for transcription factor PCR arrays described below (n=3 per condition). RNA was isolated using the Qiagen RNeasy kit, according to the manufacturer's protocol. For standard quantitative realtime PCR, 500ng of total RNA was DNAse I treated (Invitrogen) and reverse transcribed using Superscript II (Invitrogen) reverse transcriptase. 20ng of cDNA were used in SYBR Green realtime PCR reactions that were performed in duplicate and analyzed on a Step-One realtime PCR machine (Applied Biosystems). ASIC1, ASIC3, and GAPDH primer sequences (forward and reverse) were obtained from Ellit et al. (83) and GFR2, GFR3, trkA, trkB, and trkC obtained from Jankowski et al (51) for realtime PCR reactions. Primer sequences used for P2X3, P2X4, P2X5 and GFRα1 have also been detailed previously (1, 30) .
Cycle time (Ct) values for all targets were all normalized to a GAPDH internal control. Ct values (used to determine fold change after injury) were then obtained by subtracting the normalized target gene's Ct value from naive controls. Then fold change was determined as 2 Ct (Applied Biosystems). The error of the difference in means is then also calculated for the fold-change. Values were then converted and reported as a percent change where 2-fold change = 100% change.
Retrograde labeling, DRG dissociation and GDNF treatments.
To isolate afferents innervating the forepaw muscles, mice were anesthetized under isoflurane and 10L of 4% fluorogold (FG; Fluorochrome) in 0.9%NaCl was injected into the right forepaw muscles using a syringe with 30g needle similar to that described previously (9) . After 10d, mice were anesthetized and intracardially For quantification, five randomly selected fields from a given coverslip from each condition (n=5-7 per group)
were imaged at 20x on a Leica inverted fluorescence microscope and analyzed offline using Adobe Photoshop. 
